Drug shortage
Tobramycin Solution · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · To Be Discontinued · updated Jun 16, 2025
Key facts
| Generic name | Tobramycin Solution |
|---|---|
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Tobramycin, Solution, 300 mg/5 mL (NDC 0093-4085-63) |
| Dosage form | Solution |
| Status | To Be Discontinued |
| Therapeutic category | Pulmonary/Allergy |
| Package NDCs | 0093-4085-63 |
| First posted | Jun 16, 2025 |
| Last updated | Jun 16, 2025 |
| Discontinued | Jun 16, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: